|
 |
AnastrozoleThis page contains recent news articles, when available, and an overview of Anastrozole but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Anastrozole (when available) Anastrozole is a potent and selective non-steroidal aromatase inhibitor indicated for the treatment of advanced breast cancer in post-menopausal women with disease progression following tamoxifen therapy. Many breast cancers have estrogen receptors and growth of these tumors can be stimulated by estrogens. In post-menopausal women, the principal source of circulating estrogen (primarily estradiol) is conversion of adrenally-generated androstenedione to estrone by aromatase in peripheral tissues, such as adipose tissue, with further conversion of estrone to estradiol. Many breast cancers also contain aromatase; the importance of tumor-generated estrogens is uncertain. Treatment of breast cancer has included efforts to decrease estrogen levels by ovariectomy premenopausally and by use of anti-estrogens and progestational agents both pre- and post-menopausally, and these interventions lead to decreased tumor mass or delayed progression of tumor growth in some women. Anastrozole is a potent and selective non-steroidal aromatase inhibitor. It significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone. For treatment of advanced breast cancer. Mechanism Of Action: Anastrozole selectively inhibits aromatase. The principal source of circulating estrogen (primarily estradiol) is conversion of adrenally-generated androstenedione to estrone by aromatase in peripheral tissues. Therefore, aromatase inhibition leads to a decrease in circulatin estrogen, leading to a decreased tumor mass or delayed progression of tumor growth in some women. News Articles on Anastrozole Switching To Letrozole Helps Breast Cancer Patients With Anastrozole-Related ... - 04 Jan 2010 Postmenopausal women with hormone receptor-positive (HR+) breast cancer who develop arthralgia and/or myalgia (A/M) while being treated with anastrozole may ... Medical News Today ê´€ì ˆí†µìœ¼ë¡œ '아리미ë?±ìŠ¤' 사용 불가 'ë ˆíŠ¸ë¡œì¡¸'ë¡œ 바꾸세요 - 04 Jan 2010 ...아리미ë?±ìŠ¤(Arimidex, anastrozole) 사용과 ì—°ê´€ë?œ 류마티스성 ì¦?ìƒ?ì?´ 있는 ìœ ë°©ì•”ì?„ 앓는 환ìž?ì?˜ 경우 아리미ë?±ìŠ¤ ëŒ€ì‹ ë ˆíŠ¸ë¡œì¡¸(Letrozole) ë¡œ 약물ì?„ 바꾸는 것ì?´ ... 메디컬투데이 SABCS: Higher Dose of Fulvestrant Slows Breast Cancer - Dec 14, 2009 Results of another multinational study demonstrated no advantage for adding fulvestrant to anastrozole (Arimidex). Time to progression and overall survival ... MedPage Today Managing Bone Density and Reducing Breast Cancer: Role of Bisphosphonates - Dec 12, 2009 Anastrozole, currently sold as Arimidex by AstraZeneca, is scheduled to go off patent within the next few years. "Women who are on Medicare tend to go with ... MedIndia Aromatase inhibition increased testosterone, decreased estradiol, BMD in older men - Dec 23, 2009 Aromatase inhibition with daily anastrozole does not appear to improve the skeletal health of older men with low testosterone levels, new data suggested. ... Endocrine Today Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS - Dec 14, 2009 Dr. McCaig and colleagues recruited 120 women diagnosed with invasive breast cancer into an open-label trial and assigned 34 to receive anastrozole 1 mg a ... DG News Commercial Insight: Antihormonal Cancer Therapies - New Report Published - Jan 3, 2010 In 2008, Arimidex (anastrozole; AstraZeneca), Lupron (leuprolide; Takeda/Abbott) and Casodex (bicalutamide; AstraZeneca) were the three leading antihormonal ... OfficialWire (press release) Tamoxifen, Endoxifen, and CYP2D6: The Rules for Evaluating a Predictive Factor - Dec 17, 2009 Forbes JF, Cuzick J, Buzdar A, et al: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ... Cancer Network SABCS: Vitamin D Reduces Aromatase Inhibitor Pain - Dec 15, 2009 ..."Larger studies are needed to confirm these findings, but this pilot study suggests that high-dose vitamin D significantly improves anastrozole-induced ... MedPage Today Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May ... - Dec 10, 2009 ...(i) First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus ... CNNMoney.com (press release) Breaking news: James Ray drugs and disease - Dec 31, 2009 Anastrozole is most commonly prescribed after breast cancer surgery, so why was it prescribed to James Ray? My guess is because it's also used by athletes ... Examiner.com Non-adherence Rate for Adjuvant Hormonal Therapy for Breast Cancer is 40% - Dec 29, 2009 Researchers from Germany have also reported that postmenopausal women with localized breast cancer taking adjuvant Arimidex® (anastrozole) for localized ... Cancer Consultants Nexavar to make breast cancer drugs work longer - Dec 12, 2009 Aromatase inhibitors include anastrozole, made by AstraZeneca under the brand name Arimidex, and exemestane, made by Pfizer Inc, under the brand name ... TopNews United States Bisphosphonates and Beyond: Managing Bone Density and Reducing Breast Cancer - Dec 12, 2009 Anastrozole, currently sold as Arimidex by AstraZeneca, is scheduled to go off patent within the next few years. "Women who are on Medicare tend to go with ... Healthcanal.com Nueva alternativa contra el cáncer de mama - Jan 1, 2010 El estudio FACT (Fulvestrant and Anastrozole in Combination Trial-Estudio de Fulvestrant y Anastrozole Combinados), también presentado en el SABCS 2009, ... El Heraldo de Tabasco Инхибирането на ароматазата има малко ползи и повече вреди при мъже Ñ? ниÑ?ък ... - Dec 27, 2009 ТерапиÑ?та Ñ? anastrozole може да покачи теÑ?тоÑ?тероновите нива при по-възраÑ?тните мъже, но на цената на намалена коÑ?тна минерална плътноÑ?Ñ‚, докладват лекари в ... DoctorBG.com Generic Name: Anastrozole, cancer - Nov 11, 2009 Arimidex is approved for postmenopausal women with hormone receptor-positive early breast cancer. Arimidex is a hormonal treatment that helps fight breast ... Pattaya Daily News Serum estradiol should be monitored not only during the peri-menopausal period ... - Nov 13, 2009 For this study, we chose anastrozole as the AI. The assays of those hormones were outsourced to a commercial clinical laboratory. ... 7thSpace Interactive (press release) Breast Cancer Lawsuit Alleged Needless Suffering, Death - Nov 1, 2009 ...tumors are being strengthened by estrogen and progesterone can be treated with anti-estrogen prescription drugs, such as Tamoxifen and Anastrozole. ... Consumer Affairs Fighting Breast Cancer - Oct 21, 2009 Since 2005, AmeriCares has delivered more than $5.5 million worth of the breast cancer drugs tamoxifen and anastrozole. Initiatives are being developed to ... Reuters AlertNet Breast-cancer patients get $17.5-million settlement - Oct 30, 2009 If so, drugs like Tamoxifen and Anastrozole can be given to block these hormones. At least 425 patients received incorrect test results between 1997 and ... Globe and Mail BREAKING NEWS: AstraZeneca sales boosted by swine flu vaccine - Oct 29, 2009 Turnover of the breast cancer drug Arimidex (anastrozole) were up 2% to $476 million, while generic competition to Casodex (bicalutamide) saw the drug fall ... Pharma Times Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative ... - Oct 30, 2009 In 2008, Arimidex (anastrozole; AstraZeneca), Lupron (leuprolide; Takeda/Abbott) and Casodex (bicalutamide; AstraZeneca) were the three leading antihormonal ... PRMinds (press release) æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...atorvastatin), 'ì•¡í† ìŠ¤'(Actos, pioglitazone), '미ë?¼íŽ™ìŠ¤'(Mirapex, pramipexole)ê°€, 2012ë…„ì—” '아리미ë?±ìŠ¤'(Arimidex, anastrozole), 'ì½”ìž?'(Cozaar, ... 디지틀보사 Brand Names/Synonyms: Anastrozole is also known by the following brand names and/or synonymsAnastrole; Anastrozol; Anastrozole; Anastrozole [Usan:Ban:Inn]; Arimidex; CHEMBANK1630; ICI-D 1033; ZD 1033 Drug Category: Anastrozole is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BG03 Dosage Forms: tablets containing 1mg anastrozole Absorption: Absorbed into the systemic cirulation, and food does not affect the extent of absorption. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-[3-(1-cyano-1-methyl-ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
